IDIBAPS’ Inflammation and repair in respiratory diseases group is part of the collaborative RESPIRE-EXCEL project coordinated by Martijn Nawijn from1
Climate change has become one of the greatest challenges for public health worldwide. As indicated by the World Health Organisation (WHO), global war1
Interview with Dr Catia Cilloniz, a microbiologist and doctor of medicine at the applied research group on respiratory infections and critical illnes1
Being physically active and avoiding a sedentary lifestyle is one of the key factors in preventing respiratory infections in patients with bronchiect1
One of the most important components in treating patients with interstitial lung disease, such as pulmonary fibrosis, is oxygen therapy. Nevertheless1
A high percentage of patients who have suffered serious illness as a result of COVID-19, for example pneumonia, continue to experience after-effects1
Lung cancer continues to have the highest mortality of all malignant neoplasms, both in men and women. Despite advances in treatment, global survival1
Active smokers who have chronic obstructive pulmonary disease (COPD) are more likely to present serious forms of COVID-19. There are yet no studies c1
Approximately 800,000 children and 1 million elderly people died of pneumonia around the world in 2017. Nevertheless, the severity of pneumonia is of1
SARS-CoV-2 is a virus that affects people with respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibrosi1
